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▼The process of translation initiation in prokaryotic and
eukaryoticsystems follows well characterized but quite dis-
tinct pathways. Translation generally initiates from an AUG
codon for both systems, but requirements for the flank-
ing sequences controlling initiation from this codon differ
markedly.
Prokaryotic translation, for example, is dependent upon
binding of the 16S rRNA and the initiator tRNA to the ri-
bosome binding site (RBS) on themRNA. Within the RBS
a polypurine tract known as the Shine−Dalgarno(SD) se-
quence which is located a variable distance upstream from
the initiatorAUG is critical for orienting binding of the
16S rRNA (Ref. 1). By contrast, efficient vertebrate transla-
tion initiation is heavily dependent upon sequences imme-
diately flanking the initiator codon, the optimal sequence
of this region (ACCA/GCCAUGG) is known as the Kozak
sequence (Ref. 2, 3).
Given that it would often be of great utility to express
recombinant proteins in both eukaryotic and prokaryotic
cells from the same vector, we sought to create an artifical
element that would direct high level expression of proteins
in both enviroments. Given that the regulatory element
for prokaryotic initiation, namely the SD sequence, lies a
variable distance(on average some 7 nucleotides) (Ref. 1)
upstream from the initiator AUG, we reasoned this would
allow insertion of an optimal Kozak sequence immediately
adjacent and downstream from the SD to direct potentially
high level initiationof vertebrate translation.
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Accordingly, we designed a putative combined prokary-
otic/vertebrate translation initiation site with a single
ATG codon, by inserting a double-stranded oligo (upper
strand, 5’-AGCTTTAAGAAGGAGATACCAC; lower strand,
5’-CATGGTGGTATCTCCTTCTTAA) into a HindIII−NcoI
cut pCATCH-NLS vector (Ref. 4) creatinga vector (pCom;
Table 1) with a consensus SD sequence (Ref. 1) imme-
diately followed by an optimal Kozak sequence (Ref. 2).
As an alternative strategy we separated the eukaryotic
and prokaryotic initiation elements as depictedin Table
1 by inserting a double-stranded oligo (upper strand, 5’-
AGCTTACCACCATGGTTTTAGAAGGAGATATACA;lower
strand, 5’-CATGTGTATATCTCCTTCTAAAACCATGGTGGT
A) into a HindIII−NcoIcut pCATCH-NLS vector (Ref. 4)
creating the vector pSep. In this configuration, eukaryotic
translation is driven by an optimal Kozak sequence at
the 5’ end of the message and prokaryotic translation is
directed by a consensus SD motif upstream of a second
ATG codon. The pCATCH-NLS vector, which candirect
high level mammalian cell protein expression (Ref. 4)
and upon which these constructs are based, has a FLAG
epitope (Ref. 4) at the amino terminus permitting the
ready and specific identification of proteins produced from
these vectors. We subcloned a partial cDNA construct from
the hygromycin resistance cassette downstream of and
in frame with the initiator ATGs of pCATCH-NLS, pCom
and pSep in order to analyse the expression levels of these
variants in both Escherichia coliand mammalian cells. The
resultant recombinant vectors we termed pCATCH-NLS/H,
pCom/Hand pSep/H. We observed that the expression
levels from pCom/H and pSep/Hwere comparable in E. coli,
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Shine Dalgarno AGG ... 6-9N ... ATG
(primary structure)
Combined ATG AAGGAGATACCACCATGG
Separated ATGs ACCACCATGG ...6N ... AAGGAG ...8N ... ATGG
aThe optimal translation initiation elements formammalian (Kozak
consensus; bold) or prokaryotic (Shine-Dalgarno; italic) are as indicated.
Configurations for the combined initiator ATG (pCom)and for the
separated initiator ATGs (pSep) are as depicted.
indicating that both can function to direct translation in
prokaryotic cells (Fig. 1, lanes 5 and 6). pCATCH-NLS/H
is unable to direct expression in prokaryotic cells (data
not shown). In addition, high levels of the FLAG tagged
proteins were produced by both the pSep/H and pCom/H
vectors in mammalian cells, compared with the optimized
mammalian expression vector pCATCH-NLS (Fig. 1, com-
pare lanes 3 and 4 with 2). Furthermore, there appears to be
no obvious preference with respect to translation efficiency
for either of the two configurations of translation control
elements.
These findings both extend the range of translation con-
trol elements able to function across species and at the
same time imply that the sequence constraints regarding
the design of such elements are more relaxed than previ-
ously thought (Ref. 5). Hence, specific sequences of partic-
ular translation control elements that are able to function
across species boundaries, could be designed to suit differ-
ent downstream applications.
Protocols
Either of the two dual-expression cassettes outlined in Table
1 maybe inserted into an expression vector containing a
eukaryotic promotor(e.g., CMV promoter) followed by a
prokaryotic one (e.g., T7 promoter). Any protein cloned
downstream of these cassettes can now be efficiently ex-
pressedin a prokaryotic (protocol A) and eukaryotic (proto-
col B) system.
Western blots using the CMV promotor (eukaryotic) up-
stream of the T7promotor (prokaryotic) can be performed
as follows.
Protocol A
Transform vector into a T7 RNA polymerase express-
ing an E. colistrain such as NovaBlue (Novagen) or
BL21[DE3]lysS (Novagen). Picka single colony and grow
in 1 ml LB at 30◦C overnight. Induce T7 RNApolymerase
expression for 4 h with 1 mM isopropylthiogalactoside
(IPTG).Spin down and resuspend pellet in 100 µl loading
buffer (Ref. 4). Load 10 µl onto a polyacrylamide gel, plot
and visualize proteinas described (Ref. 4).
Protocol B
Transfect mammalian cells (e.g., 293T cells) at 50%
confluency using lipofectamine (Gibco BRL). Harvest cells
36 h later and prepare wholecell extracts as described (Ref.
FIGURE 1. Analysis of protein expression in transfected human 293T cells (lanes 1to 4) and in transformed E. colicells (lanes 5 and 6). Westernblots
were probed with an anti-FLAG M2 monoclonal antibody (Kodak) asdescribed (Ref. 4). Lane 1, no DNA; lane 2, pCatch-NLS/H; lanes 3 and 5,pSep/H;
lanes 4 and 6, pCom/H.
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4). Load equal amounts of proteins ontoa polyacrylamide
gel, plot and visualize protein as described (Ref. 4).
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Products Used
lipofectAMINE: lipofectAMINE from Life Tech-
nologies (Gibco BRL)
lipofectAMINE: lipofectAMINE from Life Tech-
nologies (Gibco BRL)
monoclonal antibody: monoclonal antibody
from Babco
monoclonal antibody: monoclonal antibody
from Babco
monoclonal antibody: monoclonal antibody
from Amersham Pharmacia Biotech
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